MIMEDX Promotes Marion Snyder to Chief of Staff, Senior Vice President, Government Affairs
August 12, 2021 08:30 ET
|
MiMedx Group, Inc
Promotion Recognizes Skilled Leadership and Contributions to MIMEDX’s Continued Growth MARIETTA, Ga., Aug. 12, 2021 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the...
MIMEDX Announces Second Quarter 2021 Operating and Financial Results
August 03, 2021 17:22 ET
|
MiMedx Group, Inc
Second Quarter Net Sales Increase 27% to $68.2 million Versus Q2 2020 On Track to Deliver Topline Results for Late-Stage Musculoskeletal Pipeline in Late Summer Company to Host Conference Call on...
MIMEDX to Host Second Quarter 2021 Operating and Financial Results Conference Call on August 4
July 20, 2021 08:00 ET
|
MiMedx Group, Inc
MARIETTA, Ga., July 20, 2021 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), an industry leader in utilizing amniotic tissue as a platform for regenerative...
NAACP to Present Historic Spingarn Medal to Regenerative Engineering Pioneer Cato T. Laurencin, M.D., Ph.D., at 112th Annual Convention
July 14, 2021 09:00 ET
|
MiMedx Group, Inc
MIMEDX Applauds Dr. Laurencin on Receiving NAACP’s Highest Honor for His Contributions to Emerging Medical Sciences that Advance Human Healing MARIETTA, Ga., July 14, 2021 (GLOBE NEWSWIRE) --...
MIMEDX Joins Russell 3000® and 2000® Indexes
June 28, 2021 08:00 ET
|
MiMedx Group, Inc
MARIETTA, Ga., June 28, 2021 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), an industry leader in utilizing amniotic tissue as a platform for regenerative...
MIMEDX to Present at the Raymond James 2021 Human Health Innovation Conference
June 16, 2021 08:00 ET
|
MiMedx Group, Inc
MARIETTA, Ga, June 16, 2021 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), an industry leader in utilizing amniotic tissue as a platform for regenerative...
New Study Demonstrates Potential for MIMEDX Purion® Processed Dehydrated Human Amnion/Chorion Membrane to Modulate Pathological Scar Tissue Formation
June 15, 2021 16:54 ET
|
MiMedx Group, Inc
Proposed Mechanism Suggests Potential Path to Improve Outcomes in Clinical Applications where the Regulation of Excessive Fibrosis Can Promote a Normal Healing Response Complex Nature of MIMEDX dHACM...
MIMEDX Receives Regulatory Approval to Commercialize EPIFIX® in Japan
June 08, 2021 08:30 ET
|
MiMedx Group, Inc
Availability of EPIFIX Allografts Expected Early 2022 Approval Makes it Possible to Bring EPIFIX’s Healing Properties to as Many as 100,000 New Patients Annually MARIETTA, Ga., June 08, 2021 ...
MIMEDX to Participate at the Jefferies Virtual Healthcare Conference
May 27, 2021 08:00 ET
|
MiMedx Group, Inc
MARIETTA, Ga., May 27, 2021 (GLOBE NEWSWIRE) -- MIMEDX Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), an industry leader in utilizing amniotic tissue as a platform for regenerative...
MIMEDX Reminds Shareholders to Pre-Register for the Upcoming Virtual 2021 Annual Meeting of Shareholders
May 25, 2021 08:30 ET
|
MiMedx Group, Inc
Deadline to Pre-Register Extended to May 26, 2021 at 10:00 a.m. Eastern Pre-Registration Required to Attend Annual Meeting Visit www.votemimedx.com for Instructions on How to Pre-Register ...